Menopause differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Menopause}} {{CMG}} {{RA}} <br /> == Overview == Menopause should be differentiated from other diseases presenting with menstrual irregularities (oligomenorr..." |
No edit summary |
||
(9 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{CMG}} {{RA}} | {{CMG}} {{RA}} | ||
== Overview == | |||
[[Menopause]] should be differentiated from other [[diseases]] presenting with [[menstrual irregularities]] ([[oligomenorrhea]]/[[amenorrhea]]) | ==Overview== | ||
[[Menopause]] should be differentiated from other [[diseases]] presenting with [[menstrual irregularities]] ([[oligomenorrhea]]/[[amenorrhea]]) that are include [[Sheehan's syndrome]], [[Lymphocytic hypophysitis]], [[Pituitary apoplexy]], [[Empty sella syndrome]], [[Pituitary]] [[cachexia]], [[Primary hypothyroidism|Hypothyroidism]], [[Hypogonadotropic hypogonadism]], [[Prolactin|Hypoprolactinemia]], [[Primary adrenal insufficiency]]/[[Addison's disease]]. | |||
==Differential diagnosis of menopause from other diseases== | ==Differential diagnosis of menopause from other diseases== | ||
<ref name="pmid9541295">{{cite journal |vauthors=Sato N, Sze G, Endo K |title=Hypophysitis: endocrinologic and dynamic MR findings |journal=AJNR Am J Neuroradiol |volume=19 |issue=3 |pages=439–44 |year=1998 |pmid=9541295 |doi= |url=}}</ref><ref name="pmid7758238">{{cite journal |vauthors=Powrie JK, Powell M, Ayers AB, Lowy C, Sönksen PH |title=Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature |journal=Clin. Endocrinol. (Oxf) |volume=42 |issue=3 |pages=315–22 |year=1995 |pmid=7758238 |doi= |url=}}</ref><ref name="pmid26262437">{{cite journal |vauthors=Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S |title=Diagnosis of Primary Hypophysitis in Germany |journal=J. Clin. Endocrinol. Metab. |volume=100 |issue=10 |pages=3841–9 |year=2015 |pmid=26262437 |doi=10.1210/jc.2015-2152 |url=}}</ref><ref name="pmid7629223">{{cite journal |vauthors=Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S |title=Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings |journal=J. Clin. Endocrinol. Metab. |volume=80 |issue=8 |pages=2302–11 |year=1995 |pmid=7629223 |doi=10.1210/jcem.80.8.7629223 |url=}}</ref><ref name="pmid8345854">{{cite journal |vauthors=Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H |title=Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus |journal=N. Engl. J. Med. |volume=329 |issue=10 |pages=683–9 |year=1993 |pmid=8345854 |doi=10.1056/NEJM199309023291002 |url=}}</ref><ref name="pmid21668725">{{cite journal |vauthors=Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS |title=Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman |journal=Emerg Med Australas |volume=23 |issue=3 |pages=372–5 |year=2011 |pmid=21668725 |doi=10.1111/j.1742-6723.2011.01425.x |url=}}</ref><ref name="pmid9747750">{{cite journal |vauthors=Dejager S, Gerber S, Foubert L, Turpin G |title=Sheehan's syndrome: differential diagnosis in the acute phase |journal=J. Intern. Med. |volume=244 |issue=3 |pages=261–6 |year=1998 |pmid=9747750 |doi= |url=}}</ref> | |||
<small> | <small> | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 30: | Line 31: | ||
|Acute | |Acute | ||
|<nowiki>++</nowiki> | |<nowiki>++</nowiki> | ||
| | | ++ | ||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | ||
|Symptoms of: | |Symptoms of: | ||
Line 40: | Line 41: | ||
*[[Breast tissue]] [[atrophy]] | *[[Breast tissue]] [[atrophy]] | ||
* Decreased [[axillary]] and [[pubic]] hair growth | *Decreased [[axillary]] and [[pubic]] hair growth | ||
| | | | ||
*[[Pancytopenia]] | *[[Pancytopenia]] | ||
Line 48: | Line 49: | ||
*[[Hyponatremia]] | *[[Hyponatremia]] | ||
* Low [[fasting plasma glucose]] | *Low [[fasting plasma glucose]] | ||
* Decreased levels of [[anterior pituitary]] [[hormones]] in blood | *Decreased levels of [[anterior pituitary]] [[hormones]] in blood | ||
| | | | ||
* Clinical diagnosis | *Clinical diagnosis | ||
* Most senitive test: Low baseline [[prolactin]] levels w/o response to [[Thyrotropin-releasing hormone|TRH]] | *Most senitive test: Low baseline [[prolactin]] levels w/o response to [[Thyrotropin-releasing hormone|TRH]] | ||
|CT/MRI: | |CT/MRI: | ||
* Sequential changes of pituitary enlargement followed by: | *Sequential changes of pituitary enlargement followed by: | ||
* Shrinkage and [[necrosis]] leading to decreased sellar volume or [[empty sella]] | *Shrinkage and [[necrosis]] leading to decreased sellar volume or [[empty sella]] | ||
| | | | ||
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | *Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | ||
|- | |- | ||
![[Lymphocytic hypophysitis]] | ![[Lymphocytic hypophysitis]] | ||
Line 69: | Line 70: | ||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | ||
| | | | ||
* Associated with [[autoimmune]] conditions | *Associated with [[autoimmune]] conditions | ||
* Generalized [[headache]] | *Generalized [[headache]] | ||
* Retro-orbital or Bitemporal [[pain]] | *Retro-orbital or Bitemporal [[pain]] | ||
* Mass lesion effect such as [[Visual field defect|visual field defects]] | *Mass lesion effect such as [[Visual field defect|visual field defects]] | ||
| | | | ||
*[[Diabetes insipidus|DI]] | *[[Diabetes insipidus|DI]] | ||
Line 81: | Line 82: | ||
*[[Autoimmune]] [[thyroiditis]] | *[[Autoimmune]] [[thyroiditis]] | ||
| | | | ||
* Decreased pituitary hormones([[Gonadotropins]] most common) | *Decreased pituitary hormones([[Gonadotropins]] most common) | ||
*[[Hyperprolactinemia]](40%) | *[[Hyperprolactinemia]](40%) | ||
Line 91: | Line 92: | ||
*[[CT]] & [[MRI]]: Features of a [[Pituitary gland|pituitary]] [[mass]] | *[[CT]] & [[MRI]]: Features of a [[Pituitary gland|pituitary]] [[mass]] | ||
* Diffuse and homogeneous contrast enhancement | *Diffuse and homogeneous contrast enhancement | ||
|[[Assay|Assays]] for: | |[[Assay|Assays]] for: | ||
* Anti-TPO | *Anti-TPO | ||
* Anti-Tg Ab | *Anti-Tg Ab | ||
|- | |- | ||
![[Pituitary apoplexy]] | ![[Pituitary apoplexy]] | ||
Line 104: | Line 105: | ||
|Severe [[headache]] | |Severe [[headache]] | ||
*[[Nausea and vomiting]] | *[[Nausea and vomiting]] | ||
* Paralysis of eye muscles ([[diplopia]]) | *Paralysis of eye muscles ([[diplopia]]) | ||
* Changes in vision | *Changes in vision | ||
| | | | ||
*[[Visual acuity]] defects | *[[Visual acuity]] defects | ||
Line 112: | Line 113: | ||
| | | | ||
* Decreased levels of [[anterior]] pituitary hormones in blood. | *Decreased levels of [[anterior]] pituitary hormones in blood. | ||
| | | | ||
*[[Magnetic resonance imaging|MRI]] | *[[Magnetic resonance imaging|MRI]] | ||
Line 136: | Line 137: | ||
*[[Headache]] | *[[Headache]] | ||
* Low [[libido]] | *Low [[libido]] | ||
| | | | ||
* Signs of raised [[intracranial pressure]] may be present | *Signs of raised [[intracranial pressure]] may be present | ||
*[[Nipple discharge|Nipple]] discharge | *[[Nipple discharge|Nipple]] discharge | ||
| | | | ||
* Decreased levels of pituitary hormones in the blood. | *Decreased levels of pituitary hormones in the blood. | ||
| | | | ||
*[[MRI]] | *[[MRI]] | ||
Line 149: | Line 150: | ||
*[[Empty sella]] containing [[Cerebrospinal fluid|CSF]] | *[[Empty sella]] containing [[Cerebrospinal fluid|CSF]] | ||
| | | | ||
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | *Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | ||
|- | |- | ||
![[Simmond's Disease|Simmonds' disease]]/[[Pituitary]] [[cachexia]] | ![[Simmond's Disease|Simmonds' disease]]/[[Pituitary]] [[cachexia]] | ||
|Chronic | |Chronic | ||
|<nowiki>+/-</nowiki> | |<nowiki>+/-</nowiki> | ||
| | | + | ||
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | |[[Oligomenorrhea|Oligo]]/[[amenorrhea]] | ||
| | | | ||
Line 160: | Line 161: | ||
*[[Premature aging|Premature]] aging | *[[Premature aging|Premature]] aging | ||
| | | | ||
* Progressive [[emaciation]] | *Progressive [[emaciation]] | ||
* Loss of body hair | *Loss of body hair | ||
| | | | ||
* Decreased levels of anterior pituitary hormones in the blood. | *Decreased levels of anterior pituitary hormones in the blood. | ||
| | | | ||
*[[Magnetic resonance imaging|MRI]] | *[[Magnetic resonance imaging|MRI]] | ||
| | | | ||
* Done to rule out any pituitary cause | *Done to rule out any pituitary cause | ||
| | | | ||
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | *Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests) | ||
|- | |- | ||
![[Primary hypothyroidism|Hypothyroidism]] | ![[Primary hypothyroidism|Hypothyroidism]] | ||
Line 178: | Line 179: | ||
|[[Oligomenorrhea]]/[[menorrhagia]] | |[[Oligomenorrhea]]/[[menorrhagia]] | ||
| | | | ||
* Cold intolerance | *Cold intolerance | ||
*[[Constipation]] | *[[Constipation]] | ||
| | | | ||
* Dry skin | *Dry skin | ||
*[[Bradycardia]] | *[[Bradycardia]] | ||
* Hair loss | *Hair loss | ||
*[[Myxedema]] | *[[Myxedema]] | ||
* Delayed relaxation phase of deep [[Tendon reflex|tendon reflexes]] | *Delayed relaxation phase of deep [[Tendon reflex|tendon reflexes]] | ||
| | | | ||
* Low [[T3]],[[T4]] | *Low [[T3]],[[T4]] | ||
| | | | ||
*[[TSH]] levels | *[[TSH]] levels | ||
| | | | ||
* Done to rule out any pituitary cause | *Done to rule out any pituitary cause | ||
| | | | ||
*Assays for anti-TPO and anti-Tg Ab | *Assays for anti-TPO and anti-Tg Ab | ||
Line 209: | Line 210: | ||
*[[Hot flushes]] | *[[Hot flushes]] | ||
* Energy and mood changes | *Energy and mood changes | ||
* Decreased [[libido]] | *Decreased [[libido]] | ||
| | | | ||
*[[Breast tissue]] [[atrophy]] | *[[Breast tissue]] [[atrophy]] | ||
* Decreased [[maturation]] of [[vaginal]] [[mucosa]] | *Decreased [[maturation]] of [[vaginal]] [[mucosa]] | ||
| | | | ||
* Low [[estrogen]], [[testosterone]] | *Low [[estrogen]], [[testosterone]] | ||
* High [[FSH]]/[[Luteinizing hormone|LH]] | *High [[FSH]]/[[Luteinizing hormone|LH]] | ||
| | | | ||
*[[FSH]] | *[[FSH]] | ||
*[[Luteinizing hormone|LH]] | *[[Luteinizing hormone|LH]] | ||
| | | | ||
* Done to rule out any pituitary cause | *Done to rule out any pituitary cause | ||
| | | | ||
* Genetic tests ([[karyotype]]) | *Genetic tests ([[karyotype]]) | ||
* Measurement of total and free [[testosterone]] and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] concentrations | *Measurement of total and free [[testosterone]] and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] concentrations | ||
|- | |- | ||
!Hypoprolactinemia | !Hypoprolactinemia | ||
Line 235: | Line 236: | ||
| | | | ||
*[[Infertility]] | *[[Infertility]] | ||
* Subfertility | *Subfertility | ||
| | | | ||
* Puerperal agalactogenesis | *Puerperal agalactogenesis | ||
| | | | ||
* No workup is necessary | *No workup is necessary | ||
| | | | ||
* Decreased prolactin levels | *Decreased prolactin levels | ||
| | | | ||
* Done to rule out any pituitary cause | *Done to rule out any pituitary cause | ||
| | | | ||
*[[Prolactin]] assay in [[3rd trimester]] | *[[Prolactin]] assay in [[3rd trimester]] | ||
Line 260: | Line 261: | ||
*[[Polydipsia]] | *[[Polydipsia]] | ||
* Features of [[hypothyroidism]] and [[hypoadrenalism]] | *Features of [[hypothyroidism]] and [[hypoadrenalism]] | ||
| | | | ||
*[[Growth failure]] | *[[Growth failure]] | ||
* B/L [[hemianopsia]] | *B/L [[hemianopsia]] | ||
*[[Papilledema]] | *[[Papilledema]] | ||
| | | | ||
* All pituitary hormones decreased | *All pituitary hormones decreased | ||
| | | | ||
*[[Magnetic resonance imaging|MRI]] | *[[Magnetic resonance imaging|MRI]] | ||
| | | | ||
* Done to rule out any pituitary cause | *Done to rule out any pituitary cause | ||
| | | | ||
* Left hand and wrist [[radiograph]] for [[bone age]] | *Left hand and wrist [[radiograph]] for [[bone age]] | ||
|- | |- | ||
![[Primary adrenal insufficiency]]/[[Addison's disease]] | ![[Primary adrenal insufficiency]]/[[Addison's disease]] | ||
|Chronic | |Chronic | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | - | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
Line 290: | Line 291: | ||
*[[Hyperpigmentation]] | *[[Hyperpigmentation]] | ||
* loss of [[pubic]] and [[axillary]] hair | *loss of [[pubic]] and [[axillary]] hair | ||
| | | | ||
Line 297: | Line 298: | ||
*[[Plasma renin activity]] to [[Aldosterone|aldosterone ratio]] | *[[Plasma renin activity]] to [[Aldosterone|aldosterone ratio]] | ||
| | | | ||
* Abdominal [[Computed tomography|CT]] | *Abdominal [[Computed tomography|CT]] | ||
| | | | ||
* Abdominal [[Computed tomography|CT]] | *Abdominal [[Computed tomography|CT]] | ||
| | | | ||
* Serum [[cortisol]] testing | *Serum [[cortisol]] testing | ||
* Serum [[ACTH]] testing | *Serum [[ACTH]] testing | ||
* Anti-adrenal [[Antibody|Ab]] testing | *Anti-adrenal [[Antibody|Ab]] testing | ||
|- | |- | ||
![[Menopause]] | ![[Menopause]] | ||
Line 316: | Line 317: | ||
*[[Insomnia]] | *[[Insomnia]] | ||
*[[Weight gain]] and [[bloating]] | *[[Weight gain]] and [[bloating]] | ||
* Mood changes | *Mood changes | ||
| | | | ||
*[[Vaginal atrophy]] | *[[Vaginal atrophy]] | ||
* Loss of pelvic [[muscle tone]] | *Loss of pelvic [[muscle tone]] | ||
| | | | ||
* ↑ [[FSH]] | *↑ [[FSH]] | ||
* ↓ [[Estradiol]] and [[inhibin]] | *↓ [[Estradiol]] and [[inhibin]] | ||
| | | | ||
*[[FSH]] > [[LH]] | *[[FSH]] > [[LH]] | ||
Line 330: | Line 331: | ||
|} | |} | ||
<small> | <small> | ||
<br /> | <br /> | ||
Line 340: | Line 340: | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | <br />[[Category:Disease]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] |
Latest revision as of 05:19, 17 February 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Rahmah Al-Edresi, M.D.[2]
Overview
Menopause should be differentiated from other diseases presenting with menstrual irregularities (oligomenorrhea/amenorrhea) that are include Sheehan's syndrome, Lymphocytic hypophysitis, Pituitary apoplexy, Empty sella syndrome, Pituitary cachexia, Hypothyroidism, Hypogonadotropic hypogonadism, Hypoprolactinemia, Primary adrenal insufficiency/Addison's disease.
Differential diagnosis of menopause from other diseases
Diseases | Onset | Manifestations | Diagnosis | |||||||
---|---|---|---|---|---|---|---|---|---|---|
History and Symptoms | Physical examination | Laboratory findings | Gold standard | Imaging | Other investigation findings | |||||
Trumatic delivery | Lactation failure | Menstrual irregularities | Other features | |||||||
Sheehan's syndrome | Acute | ++ | ++ | Oligo/amenorrhea | Symptoms of: |
|
|
CT/MRI:
|
| |
Lymphocytic hypophysitis | Acute | +/- | + | Oligo/amenorrhea |
|
|
|
Assays for:
| ||
Pituitary apoplexy | Acute | +/- | ++ | Oligo/amenorrhea | Severe headache
|
|
|
Blood tests may be done to check: | ||
Empty sella syndrome | Chronic | - | + | Oligo/amenorrhea |
|
|
|
|
| |
Simmonds' disease/Pituitary cachexia | Chronic | +/- | + | Oligo/amenorrhea |
|
|
|
| ||
Hypothyroidism | Chronic | +/- | - | Oligomenorrhea/menorrhagia |
|
|
|
|
| |
Hypogonadotropic hypogonadism | Chronic | - | - | Oligo/amenorrhea |
|
|
|
|
| |
Hypoprolactinemia | Chronic | - | + | - |
|
|
|
|
|
|
Panhypopituitarism | Chronic | - | + | Oligo/amenorrhea |
|
|
|
|
| |
Primary adrenal insufficiency/Addison's disease | Chronic | - | - | - |
|
|
|
| ||
Menopause | Chronic | - | +/- | Oligo/amenorrhea |
|
|
Normal |
References
- ↑ Sato N, Sze G, Endo K (1998). "Hypophysitis: endocrinologic and dynamic MR findings". AJNR Am J Neuroradiol. 19 (3): 439–44. PMID 9541295.
- ↑ Powrie JK, Powell M, Ayers AB, Lowy C, Sönksen PH (1995). "Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature". Clin. Endocrinol. (Oxf). 42 (3): 315–22. PMID 7758238.
- ↑ Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S (2015). "Diagnosis of Primary Hypophysitis in Germany". J. Clin. Endocrinol. Metab. 100 (10): 3841–9. doi:10.1210/jc.2015-2152. PMID 26262437.
- ↑ Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S (1995). "Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings". J. Clin. Endocrinol. Metab. 80 (8): 2302–11. doi:10.1210/jcem.80.8.7629223. PMID 7629223.
- ↑ Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H (1993). "Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus". N. Engl. J. Med. 329 (10): 683–9. doi:10.1056/NEJM199309023291002. PMID 8345854.
- ↑ Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS (2011). "Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman". Emerg Med Australas. 23 (3): 372–5. doi:10.1111/j.1742-6723.2011.01425.x. PMID 21668725.
- ↑ Dejager S, Gerber S, Foubert L, Turpin G (1998). "Sheehan's syndrome: differential diagnosis in the acute phase". J. Intern. Med. 244 (3): 261–6. PMID 9747750.